Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 14966104)

1.

Improved outcome with dose-dense chemotherapy.

Keith B, Hall R, Scholnik A.

J Clin Oncol. 2004 Feb 15;22(4):749; author rpely 751-3. No abstract available.

2.

Dose-dense adjuvant chemotherapy for breast cancer.

Ziegler J, Citron M.

Cancer Nurs. 2006 Jul-Aug;29(4):266-72. Review.

PMID:
16871092
3.

High-dose chemotherapy for primary breast cancer: facts versus anecdotes.

Hortobagyi GN.

J Clin Oncol. 1999 Nov;17(11 Suppl):25-9. Review. No abstract available.

PMID:
10630258
4.

Dose-dense chemotherapy for primary breast cancer.

Kümmel S, Rezai M, Kimmig R, Schmid P.

Curr Opin Obstet Gynecol. 2007 Feb;19(1):75-81. Review.

PMID:
17218856
5.

Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data.

Antman KH.

J Clin Oncol. 1999 Nov;17(11 Suppl):30-4. Review. No abstract available.

PMID:
10630259
6.

Chemotherapy dose density in early-stage breast cancer and non-Hodgkin's lymphoma.

Goldspiel BR.

Pharmacotherapy. 2004 Oct;24(10):1347-57. Review.

PMID:
15628832
7.

Current status of dose-dense chemotherapy for breast cancer.

Seidman AD.

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:78-83. Review.

PMID:
16273358
8.

Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.

Budman DR.

Semin Oncol. 2004 Dec;31(6 Suppl 15):3-9. Review.

PMID:
15726532
9.

Dose intensification and breast cancer: current results and future perspectives.

Antoine EC, Khayat D.

Ann Oncol. 1996;7 Suppl 2:31-40. Review. No abstract available.

PMID:
8805947
10.

[High-dose chemotherapy for breast cancer: are we at the end or at the end of the beginning?].

Lopez M.

Clin Ter. 1999 Jul-Aug;150(4):259-62. Italian. No abstract available.

PMID:
10605161
11.

Dose-dense chemotherapy for breast cancer: the story so far.

Hudis C.

Br J Cancer. 2000 Jun;82(12):1897-9. No abstract available.

12.

Dose density by any other name.

Hryniuk W, Ragaz J, Peters W.

J Clin Oncol. 2004 Feb 15;22(4):750-1; author reply 751-3. No abstract available.

13.

Point: combination versus single-agent chemotherapy: the argument for sequential single agents.

Conlin AK, Seidman AD.

J Natl Compr Canc Netw. 2007 Sep;5(8):668-72.

PMID:
17927924
14.

Dose density in adjuvant chemotherapy for breast cancer.

Citron ML.

Cancer Invest. 2004;22(4):555-68. Review.

PMID:
15565814
15.

[In search of Eldorado. Breast cancer and intensification therapy].

Murillo Capitán E.

Med Clin (Barc). 1996 Jun 15;107(3):95-8. Spanish. No abstract available.

PMID:
8754496
16.

Re: Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer.

Vollmer RT.

J Natl Cancer Inst. 1999 Feb 3;91(3):286-7. No abstract available.

17.

Dose optimisation and intensification of cytotoxics in solid tumours supported by haematopoietic growth factors.

Le Chevalier T.

Eur J Cancer. 1994;30A(3):410-2. No abstract available.

PMID:
8204370
18.

Use of dose-dense chemotherapy in the management of breast cancer.

Norton L.

Clin Adv Hematol Oncol. 2006 Jan;4(1):36-7. Review. No abstract available.

PMID:
16562368
19.

[Dose density and dose intensity in the treatment of breast cancer].

Saintigny P, Assouad S, Gligorov J, Selle F, Roché H, Breau JL, Morère JF, Lotz JP.

Bull Cancer. 2004 Dec 1;91 Suppl 4:S244-53. Review. French.

PMID:
15899616
20.

Recent advances in the hormonal treatment of breast cancer.

Boughey JC, Buzdar AU, Hunt KK.

Curr Probl Surg. 2008 Jan;45(1):13-55. doi: 10.1067/j.cpsurg.2007.10.004. Review. No abstract available.

PMID:
18206436
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk